{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T07:48:34Z","timestamp":1780559314857,"version":"3.54.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T00:00:00Z","timestamp":1651622400000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Brazilian Journal of Infectious Diseases"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.bjid.2022.102366","type":"journal-article","created":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T02:44:58Z","timestamp":1652841898000},"page":"102366","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Susceptibility to first choice antimicrobial treatment for urinary tract infections to Escherichia coli isolates from women urine samples in community South Brazil"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6267-0155","authenticated-orcid":false,"given":"Zuleica Naomi","family":"Tano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata K.","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn Poliana","family":"Candido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana Buck","family":"Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Felipe","family":"Perugini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliana Carolina","family":"Vespero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wander Rogerio","family":"Pavanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"169","key":"10.1016\/j.bjid.2022.102366_bib0001","first-page":"1","article-title":"Ambulatory medical care utilization estimates for 2007","volume":"13","author":"Schappert","year":"2011","journal-title":"Vital Health Stat"},{"key":"10.1016\/j.bjid.2022.102366_bib0002","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nrurol.2010.190","article-title":"The epidemiology of urinary tract infection","volume":"7","author":"Foxman","year":"2010","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.bjid.2022.102366_bib0003","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0025-7125(16)30451-5","article-title":"Definitions, classification, and clinical presentation of urinary tract infections","volume":"75","author":"Johnson","year":"1991","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.bjid.2022.102366_bib0004","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1186\/s12879-017-2785-y","article-title":"Prevalence of antimicrobial resistant Escherichia coli from patients with suspected urinary tract infection in primary care, Denmark","volume":"17","author":"C\u00f3rdoba","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.bjid.2022.102366_bib0005","first-page":"1","article-title":"Community-acquired urinary tract infection by Escherichia coli in the era of antibiotic resistance","volume":"2018","author":"Lee","year":"2018","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.bjid.2022.102366_bib0006","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1590\/S1678-9946201658002","article-title":"Antibiotic resistance patterns of urinary tract infections in a Northeastern Brazilian Capital","volume":"58","author":"Cunha","year":"2016","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"10.1016\/j.bjid.2022.102366_bib0007","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1093\/cid\/ciq257","article-title":"International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases","volume":"52","author":"Gupta","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2022.102366_bib0008","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3947\/ic.2018.50.1.67","article-title":"Clinical practice guidelines for the antibiotic treatment of community-acquired urinary tract infections","volume":"50","author":"Kang","year":"2018","journal-title":"Infect Chemother"},{"key":"10.1016\/j.bjid.2022.102366_bib0009","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1476-0711-8-27","article-title":"Empiric antibiotic therapy in acute uncomplicated urinary tract infections and fluoroquinolone resistance: a prospective observational study","volume":"8","author":"Aypak","year":"2009","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.bjid.2022.102366_bib0010","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jmii.2013.08.006","article-title":"Epidemiology and risk factors of community-onset urinary tract infection caused by extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae in a medical center in Taiwan: a prospective cohort study","volume":"48","author":"Kung","year":"2015","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.bjid.2022.102366_bib0011","first-page":"115","article-title":"Sex, drugs, bugs, and age: rational selection of empirical therapy for outpatient urinary tract infection in an era of extensive antimicrobial resistance","volume":"16","author":"Rocha","year":"2012","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.bjid.2022.102366_bib0012","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.emc.2019.07.007","article-title":"Evaluation and management of urinary tract infection in the emergency department","volume":"37","author":"Dubbs","year":"2019","journal-title":"Emerg Med Clin North Am"},{"key":"10.1016\/j.bjid.2022.102366_bib0013","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.bjid.2018.10.279","article-title":"Fadel-Picheth CMT. Epidemiology of pathogens causing urinary tract infections in an urban community in southern Brazil","volume":"22","author":"Reu","year":"2018","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.bjid.2022.102366_bib0014","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.2147\/IDR.S201849","article-title":"Changing antibiotic susceptibility pattern in uropathogenic Escherichia coli over a period of 5 years in a tertiary care center","volume":"12","author":"Prasada","year":"2019","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.bjid.2022.102366_bib0015","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01834-17","article-title":"Persistent pandemic lineages of uropathogenic Escherichia coli in a College Community from 1999 to 2017","volume":"56","author":"Yamaji","year":"2018","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bjid.2022.102366_bib0016","first-page":"49","article-title":"Trimethoprim-sulfamethoxazole resistance and fosfomycin susceptibility rates in uncomplicated urinary tract infections: Time to change the antimicrobial preferences","volume":"55","author":"Guneysel","year":"2016","journal-title":"Acta Clin Croat"},{"key":"10.1016\/j.bjid.2022.102366_bib0017","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.medmal.2018.03.005","article-title":"Practice guidelines for the management of adult community-acquired urinary tract infections","volume":"48","author":"Caron","year":"2018","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.bjid.2022.102366_bib0018","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1128\/AAC.05321-11","article-title":"Determinants of quinolone versus trimethoprim-sulfamethoxazole use for outpatient urinary tract infection","volume":"56","author":"Stuck","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bjid.2022.102366_bib0019","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.3389\/fphar.2019.01498","article-title":"Treatment of cystitis by hungarian general practitioners: a prospective observational study","volume":"10","author":"Benko","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bjid.2022.102366_bib0020","doi-asserted-by":"crossref","first-page":"400","DOI":"10.4067\/S0716-10182014000400004","article-title":"Factores asociados al desarrollo de infecci\u00f3n urinaria de origen comunitario causada por Escherichia coli resistente a fluoroquinolonas. [Risk factors for community-acquired urinary tract infection caused by fluoroquinolone resistant E. coli]","volume":"31","author":"Seija","year":"2014","journal-title":"Rev Chilena Infectol"},{"key":"10.1016\/j.bjid.2022.102366_bib0021","doi-asserted-by":"crossref","first-page":"ofw159","DOI":"10.1093\/ofid\/ofw159","article-title":"Outpatient antibiotic prescribing practices for uncomplicated urinary tract infection in women in the United States, 2002-2011","volume":"3","author":"Kobayashi","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.bjid.2022.102366_bib0022","unstructured":"FDA Drug Safety Communication. FDA advises restricting fluoroquinolone antibiotic use for certain uncomplicated infections; warns about disabling side effects that can occur together. 2016."},{"key":"10.1016\/j.bjid.2022.102366_bib0023","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1177\/1060028019865224","article-title":"Evaluation of FDA boxed warning on prescribing patterns of fluoroquinolones for uncomplicated urinary tract infections","volume":"53","author":"Cowart","year":"2019","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.bjid.2022.102366_bib0024","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/pds.5018","article-title":"Outpatient fluoroquinolone prescribing patterns before and after US FDA boxed warning","volume":"29","author":"Bratsman","year":"2020","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.bjid.2022.102366_bib0025","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1128\/AAC.02897-15","article-title":"Antibiotic resistance among urinary isolates from female outpatients in the United States in 2003 and 2012","volume":"60","author":"Sanchez","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bjid.2022.102366_bib0026","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12941-018-0286-5","article-title":"An evaluation of multidrug-resistant Escherichia coli isolates in urinary tract infections from Aguascalientes, Mexico: cross-sectional study","volume":"17","author":"Ram\u00edrez-Castillo","year":"2018","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.bjid.2022.102366_bib0027","doi-asserted-by":"crossref","first-page":"403","DOI":"10.33073\/pjm-2019-048","article-title":"Antibiotic resistance among uropathogenic Escherichia coli","volume":"68","author":"Kot","year":"2019","journal-title":"Pol J Microbiol"},{"key":"10.1016\/j.bjid.2022.102366_bib0028","doi-asserted-by":"crossref","first-page":"850","DOI":"10.4103\/jfmpc.jfmpc_970_19","article-title":"Susceptibility pattern of oral antimicrobials in uncomplicated UTI: Does fosfomycin still stand effective?","volume":"9","author":"Batra","year":"2020","journal-title":"J Family Med Prim Care"},{"key":"10.1016\/j.bjid.2022.102366_bib0029","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.ijantimicag.2015.08.012","article-title":"Activity of fosfomycin and comparison of several susceptibility testing methods against contemporary urine isolates","volume":"46","author":"Hirsch","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.bjid.2022.102366_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2015.08.019","article-title":"Comparative in vitro activity of oral antimicrobial agents against Enterobacteriaceae from patients with community-acquired urinary tract infections in three European countries","volume":"22","author":"Kresken","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.bjid.2022.102366_bib0031","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1590\/S1517-83822013005000038","article-title":"Extended-spectrum \u03b2-lactamase-producing enterobacteriaceae in community-acquired urinary tract infections in S\u00e3o Lu\u00eds, Brazil","volume":"44","author":"Abreu","year":"2013","journal-title":"Braz J Microbiol"},{"key":"10.1016\/j.bjid.2022.102366_bib0032","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jgar.2016.02.003","article-title":"Multidrug resistance dissemination by extended-spectrum \u03b2-lactamase-producing Escherichia coli causing community-acquired urinary tract infection in the Central-Western Region","volume":"6","author":"Gon\u00e7alves","year":"2016","journal-title":"Brazil. J Glob Antimicrob Resist."},{"key":"10.1016\/j.bjid.2022.102366_bib0033","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00284-006-0307-z","article-title":"Prevalence of community-occurring extended spectrum beta-lactamase-producing Enterobacteriaceae in Brazil","volume":"54","author":"Minarini","year":"2007","journal-title":"Curr Microbiol"},{"key":"10.1016\/j.bjid.2022.102366_bib0034","first-page":"138","article-title":"Nosocomial and community infections due to class A extended-spectrum \u03b2-lactamase (ESBLA)-producing Escherichia coli and Klebsiella spp. in southern Brazil","volume":"15","author":"Wollheim","year":"2011","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.bjid.2022.102366_bib0035","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4103\/ijp.IJP_200_17","article-title":"Incidence of multidrug resistance and extended-spectrum beta-lactamase expression in community-acquired urinary tract infection among different age groups of patients","volume":"50","author":"Fatima","year":"2018","journal-title":"Indian J Pharmacol"},{"key":"10.1016\/j.bjid.2022.102366_bib0036","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s10096-018-3229-3","article-title":"Managing ESBL-producing Enterobacteriaceae-related urinary tract infection in primary care: a tool kit for general practitioners","volume":"37","author":"Zucconi","year":"2018","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.bjid.2022.102366_bib0037","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.diagmicrobio.2009.12.011","article-title":"Changing prevalence of Escherichia coli with CTX-M-type extended-spectrum beta-lactamases in outpatient urinary E. coli between 2003 and 2008","volume":"67","author":"Qi","year":"2010","journal-title":"Diagn Microbiol Infect Dis"}],"container-title":["The Brazilian Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S141386702200054X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S141386702200054X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T15:57:13Z","timestamp":1761407833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S141386702200054X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S141386702200054X"],"URL":"https:\/\/doi.org\/10.1016\/j.bjid.2022.102366","relation":{},"ISSN":["1413-8670"],"issn-type":[{"value":"1413-8670","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Susceptibility to first choice antimicrobial treatment for urinary tract infections to Escherichia coli isolates from women urine samples in community South Brazil","name":"articletitle","label":"Article Title"},{"value":"The Brazilian Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bjid.2022.102366","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Sociedade Brasileira de Infectologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"102366"}}